CRP to albumin ratio indicates disease activity in juvenile idiopathic arthritis patients: Study
A new study by Giulia Di Donato and team found that in individuals with juvenile idiopathic arthritis (JIA), the neutrophil to lymphocyte ratio (NLR) and the C reactive protein to albumin ratio (CAR) may provide evidence of ongoing disease activity. The findings of this study were published in the journal of BMC Rheumatology.
The most common chronic rheumatic condition in children, JIA is a major contributor to both short- and long-term impairment as well as a lower quality of life. The last 20 years have seen the introduction of combination therapy plans and targeted medicines due to increased understanding of JIA etiology. New derivative indicators have emerged as promising biomarkers of systemic inflammation and disease activity in individuals with autoimmune disorders, including rheumatoid arthritis (RA), according to recent scientific research.
Studies on adult RA patients has demonstrated a favorable relationship between disease activity, likelihood of flare, and CRP to CAR. Additionally, number of studies have raised the possibility that NLR and the platelet to lymphocyte ratio (PLR) may serve as supplementary diagnostic tools and inflammatory indicators in RA and other rheumatic disorders. The primary goal of this study was to look at the function of CAR, PLR, and NLR as possible disease activity markers in patients with non-systemic JIA (nsJIA). The second goal was to longitudinally explore the link between CAR, PLR, and NLR with the probability of flare or chronic disease activity over an 18-month period.
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.